(Q48415542)

English

Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART).

scientific article published in January 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16995830

Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART). (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16995830

anti-retroviral agent

0 references

Steven L. Zeichner

4

object named as

Steven L Zeichner

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

author name string

Staci C Martin

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16995830

Pamela L Wolters

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16995830

Mary Anne Toledo-Tamula

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16995830

Rohan Hazra

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16995830

Lucy Civitello

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16995830

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16995830

Developmental Neuropsychology

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16995830

30

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16995830

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16995830

633-657

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16995830

A longitudinal study of neuropsychological change in individuals with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Cognitive development in school-age children with vertically transmitted HIV infection

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Advances in neuroimaging for HIV-1 associated neurological dysfunction: clues to the diagnosis, pathogenesis and therapeutic monitoring.

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Executive functions in children aged 6 to 13: a dimensional and developmental study

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Verbal working memory impairment in schizophrenia patients and their first-degree relatives: evidence from the digit span task.

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

The prevalence of computed tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immune deficiency virus

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Clinical and laboratory characteristics of a large cohort of symptomatic, human immunodeficiency virus-infected infants and children. AIDS Clinical Trials Group Protocol 152 Study Team

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Antiretroviral treatment of central nervous system HIV-1 infection: a review

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Factor analysis of the WISC-R for a group of mentally retarded children and adolescents

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Declining immune function in children and adolescents with hemophilia and HIV infection: effects on neuropsychological performance. Hemophilia Growth and Development Study

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART).

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinica

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatric AIDS Clinical Trials Group 152 Study Team

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Follow-up of patients with vertically-acquired HIV infection who are more than 9 years old.

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Reservoirs for HIV infection and their persistence in the face of undetectable viral load

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

HIV-1-related central nervous system diseases

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Cognitive assessment of school-age children infected with maternally transmitted human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Cognitive decline with immunologic and virologic stability in four children with human immunodeficiency virus disease

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Receptive and expressive language function of children with symptomatic HIV infection and relationship with disease parameters: a longitudinal 24-month follow-up study

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Reversal of AIDS dementia after combination therapy with stavudine, lamivudine, and nelfinavir

1 reference

https://api.crossref.org/works/10.1207%2FS15326942DN3002_1

21 January 2018

Identifiers

10.1207/S15326942DN3002_1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16995830

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16995830

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48415542&oldid=1267466995"